Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial-Reference-Cited by-同舟云学术

Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial

Published:2023-05 Issue:5 Volume:11 Page:e693-e703
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Liu Xiaoqiu,Thompson Jennifer,Dong Haiyan,Sweeney Sedona,Li Xue,Yuan Yanli,Wang Xiaomeng,He Wangrui,Thomas Bruce,Xu Caihong,Hu Dongmei,Vassall Anna,Huan Shitong,Zhang Hui,Jiang Shiwen,Fielding Katherine,Zhao Yanlin

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Global tuberculosis report 2022,2022

2. Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review;Chimeh;Int J Tuberc Lung Dis,2020

3. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis;Imperial;Nat Med,2018

4. Implementation and community involvement in DOTS strategy: a systematic review of studies in China;Hou;Int J Tuberc Lung Dis,2012

5. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies;Alipanah;PLoS Med,2018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China;International Journal of Infectious Diseases;2024-10

2. Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial;eClinicalMedicine;2024-09

3. Transforming multidrug-resistant tuberculosis care: The potentials of telemedicine in resource-limited settings;Health Sciences Review;2024-09

4. Equity, cost and disability adjusted life years of tuberculosis treatment supported by digital adherence technologies and differentiated care in Ethiopia: a trial-based distributional cost-effectiveness analysis;2024-07-29

5. Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study;JMIR Human Factors;2024-07-23